{
    "organizations": [],
    "uuid": "d219097b758434c95b848d74bbecbc3c2052ca43",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-quidel-receives-fda-clearance-for/brief-quidel-receives-fda-clearance-for-its-instrument-idUSFWN1QN0QY",
    "ord_in_thread": 0,
    "title": "BRIEF-Quidel Receives FDA Clearance For Its Instrument",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Quidel Corp:\n* QUIDEL RECEIVES FDA CLEARANCE FOR ITS POINT-OF-CARE SOFIA® LYME FLUORESCENT IMMUNOASSAY FOR USE WITH SOFIA® 2 INSTRUMENT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-06T05:23:00.000+02:00",
    "crawled": "2018-03-06T22:18:02.126+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "quidel",
        "corp",
        "quidel",
        "receives",
        "fda",
        "clearance",
        "lyme",
        "fluorescent",
        "immunoassay",
        "use",
        "instrument",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}